Table 1.
Descriptive data of diabetic and non-diabetic inpatients with COVID-19
| SARS Positive Diabetic Patients (N = 78,554) |
PCR Positive Diabetic Patients (N = 37,338) |
|
|---|---|---|
| Age, N (%) | ||
| (Mean ± SD) | 64.6 ± 14.0 | 63.6 ± 13.6 |
| <20 yrs. old | 445 (0.6%) | 129 (0.3%) |
| 20 to 40 yrs. old | 3245 (4.1%) | 1, 6137 (4.3%) |
| 40 to 60 yrs. old | 21,728 (27.6%) | 11,618 (31.1%) |
| >60 yrs. old | 53,136 (67.6%) | 243,978 (64.2%) |
| Sex, N (%) | ||
| Female | 43,451 (55.3%) | 20,368 (54.5%) |
| Pregnancy, N(%) | 332 (0.4%) | 119 (0.3%) |
| Comorbidity, N(%) | ||
| CVD | 33,746 (42.9%) | 14,790 (39.6%) |
| COPD | 4.733(6.03%) | 1831(4.9%) |
| Kidney disease | 5928 (7.5%) | 2168 (5.8%) |
| Malignancy | 1215 (1.5%) | 401 (1.1%) |
| Liver disease | 1153 (1.4%) | 488 (1.3%) |
| Immune deficiency disorders | 345 (0.4%) | 150 (0.4%) |
| Sign &symptoms, N(%) | ||
| Dyspnea | 45,754 (58.2%) | 22,344 (59.8%) |
| Cough | 35,017 (44.5%) | 18,973 (50.8%) |
| Body temp (Mean ± SD) | 37.9 ± 0.8 | 38.0 ± 0.8 |
| Fever | 19,371 (24.6%) | 10,271 (27.5%) |
| Myalgia | 20,127 (25.6%) | 10,923 (29.3%) |
| Sore throat | 6529 (8.3%) | 3469 (9.3%) |
| Headache | 7937 (10.1%) | 4262 (11.4%) |
| Diarrhea | 3716 (4.7%) | 1910 (5.1%) |
| ICU admission | 8358 (10.6%) | 3426 (9.2%) |
| Non-invasive ventilation | 7867 (10.0%) | 3771 (10.1%) |
| Outcome, N(%) | ||
| Death | 11,428 (14.5%) | 6920 (18.5%) |
| Recovered | 44,042 (56.1%) | 20,214 (54.1%) |
| Under treatment | 23,084 (29.3%) | 10,204 (27.3%) |
| Sever Condition | 12,820 (16.3%) | 5593 (14.9%) |